"Internationality is a basic requirement for companies in the biotechnology and life science sectors to achieve and maintain competitiveness," said Dr Heinrich Cuypers of BioCon Valley. "We see considerable potential on the Polish Market. Through the sector atlas we hope to facilitate co-operation for our businesses."
According to the atlas, the main strengths of the Polish biotech sector are in the fields of research and development, with a focus on medicine, pharmacy, plant and animal breeding and environmental biotechnology. It also has a strong education system, with 21 Polish universities offering courses in biotechnology and related disciplines. Its legislation, in particular the 'gene law', is also favourable to biotech research. However, the field is being held back by limited investment and a lack of biotech specific infrastructure, in the form of science parks and incubators.
For further information, please visit:
www.scanbalt.org
|
Copyright ©European Communities, 2006 Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg â http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge. |